Sarcoma / 2014 / Article / Fig 1

Research Article

Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma

Figure 1

(a) Kaplan-Meier estimates of overall survival from the time of diagnosis according to tumor tissue of origin in all patients with high-grade osteosarcoma [,173 (256 with extraskeletal involvement and 3,917 with skeletal involvement)]. (b) Kaplan-Meier estimates of overall survival from the time of diagnosis according to tumor tissue of origin in patients aged from 0 to 17 years [,672 (6 with extraskeletal involvement and 1,666 with skeletal involvement)]. (c) Kaplan-Meier estimates of overall survival from the time of diagnosis according to tumor tissue of origin in patients aged from 18 to 32 years [ (24 with extraskeletal involvement and 825 with skeletal involvement)]. (d) Kaplan-Meier estimates of overall survival from the time of diagnosis according to tumor tissue of origin in patients aged from 33 to 59 years [ (72 with extraskeletal involvement and 752 with skeletal involvement)]. (e) Kaplan-Meier estimates of overall survival from the time of diagnosis according to tumor tissue of origin in patients aged from 60 to 99 years [ (154 with extraskeletal involvement and 674 with skeletal involvement)].
902620.fig.001a
(a)
902620.fig.001b
(b)
902620.fig.001c
(c)
902620.fig.001d
(d)
902620.fig.001e
(e)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.